Body weight and BMI play a role in determining eligibility for weight management trials, with most retatrutide studies enrolling adults with a BMI of 30 kg/m or above, or 27 kg/m or above in the presence of weight-related comorbidities such as hypertension or dyslipidaemia
This data informs three key decisions: whether to continue semaglutide at the current dose, taper and maintain, or adjust the programme before moving forward
Novo Nordisk most recently took American online pharmacy Hims and Hers to court for selling compounded versions of semaglutide at a lower cost
We check in regularly via telehealth or messaging, monitor your progress with weight, blood sugar, and side effects, adjust doses as needed based on response and tolerance, order lab work at appropriate intervals, and remain available for questions or concerns between scheduled appointments
After that initial rapid loss, the rate of weight loss tends to slow down a bit, but it doesnt stop
